Perkins Capital Management Inc has filed its 13F form on October 31, 2024 for Q3 2024 where it was disclosed a total value porftolio of $102 Million distributed in 84 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $11M, Natera, Inc. with a value of $6.91M, Microsoft Corp with a value of $5.6M, Idexx Laboratories Inc with a value of $4.9M, and Axogen, Inc. with a value of $3.97M.

Examining the 13F form we can see an increase of $116K in the current position value, from $102M to 102M.

Below you can find more details about Perkins Capital Management Inc portfolio as well as his latest detailed transactions.

Portfolio value $102 Million
Healthcare: $60.8 Million
Technology: $24.2 Million
Communication Services: $7.05 Million
Consumer Defensive: $4.65 Million
Energy: $2.58 Million
Industrials: $1.8 Million
Financial Services: $621,000

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 84
  • Current Value $102 Million
  • Prior Value $102 Million
  • Filing
  • Period Q3 2024
  • Filing Date October 31, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 4 stocks
  • Additional Purchases 11 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 49 stocks
Track This Portfolio

Track Perkins Capital Management Inc Portfolio

Follow Perkins Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.